About Us
Pioneering the Future of Cancer Treatment
Our Story
At Cistron Therapeutics, we started with a bold vision: to revolutionize cancer treatment. Our passionate team brings together AI specialists, molecular biologists, and medicinal chemists, all united by a common goal—finding potential drug candidates that can truly make a difference in the fight against cancer.
Using our innovative AI-powered platform, we can quickly and accurately analyze how drugs interact with specific cancer targets. This enables us to design tailored small molecule peptides and natural products, screening them to identify candidates that match the unique binding sites of these oncogenic targets.
Mission
Our mission is clear: to unlock the therapeutic potential of complex disease targets that traditional methods often overlook. Through our state-of-the-art AI discovery platform, we aim to identify functional natural products and small molecules capable of modulating these difficult targets, paving the way for new treatment possibilities.
Vision
We aim to be at the forefront of drug discovery by leveraging AI to address the complexities of challenging disease targets. Our vision is to transform intricate biological challenges into actionable therapies through rigorous scientific exploration and innovation. By systematically identifying and developing targeted small molecules and natural products, we aspire to create effective treatments that can significantly enhance patient outcomes and advance the future of oncology.
Scientific Advisory board
Professor Thorsten Berg
University of Leipzig, Germany
Organische Chemie/Chemische Biologie
Hauptgebäude Chemie
Johannisallee 29, Raum 155
04103 Leipzig
Telefon: +49 341 97 - 36527
Dr. Pillaiyar, Thanigaimalai
Independent Junior Group Leader
eMail: Thanigaimalai.pillaiyar@uni-tuebingen.de
Subject: Pharmaceutical/Medicinal Chemistry
phone: (+49 7071) 29 - 77458
Why Choose Our Approach
Cutting-Edge AI Meets Acceleration and Precision
At Cistron Therapeutics, we merge the latest advancements in artificial intelligence with a deep understanding of biological protein targets. By combining AI-driven insights with traditional cancer research, we’re breaking new ground in the quest for effective cancer therapies.
Key Advantages of Our Approach
Personalized Screening at Its Best
Accelerated Drug Discovery
Collaborative Expertise
Using sophisticated AI models, we analyze extensive datasets to identify screening libraries that are most likely to be effective for specific oncogenic targets. This tailored approach ensures our drug discovery efforts are focused, targeted, and optimized for success
Our AI-driven platform enables us to rapidly screen millions of compounds, significantly shortening the time required to discover and develop new cancer therapies. This means promising discoveries can move forward faster, ultimately saving time and resources.
We believe that teamwork makes a difference. At Cistron, we partner with leading research institutions, universities, and pharmaceutical companies to unite the best minds in the fight against cancer. This collaborative approach not only accelerates discovery but also enhances the likelihood of clinical success. By choosing Cistron Therapeutics, you're supporting a forward-thinking approach that blends technology, expertise, and collaboration to make a real impact in cancer treatment.
A Message from Our CEO
Welcome to Cistron Therapeutics.
At Cistron, our work is grounded in the belief that innovation and collaboration can truly transform lives. Our mission is to harness cutting-edge science and AI-driven discovery to tackle some of the most complex cancers, providing patients with treatments that are not only effective but personalized to their needs.
Throughout my career, I’ve been fortunate to contribute to significant advances in cancer drug design, with a proven track record of publications and patents from institutions like the University of Southampton, Leipzig University, and Curve Therapeutics Ltd. These experiences have shaped my commitment to pushing the boundaries of cancer research and drug discovery.
At Cistron Therapeutics, we pride ourselves on blending scientific excellence with compassion. Our AI-powered platform is designed to accelerate the discovery of small molecules and natural products, focusing on disease targets that have remained elusive to traditional methods. We believe that by approaching these challenges with dedication and empathy, we can offer hope to patients and their families.
Thank you for your interest in Cistron Therapeutics. Together, we are working toward a future where even the toughest cancers can be defeated.
Warm regards,
Nagarajan Elumalai
Director and CEO,
Cistron Therapeutics Ltd
Gallery
At Cistron Therapeutics, we believe that visual storytelling is a powerful way to showcase our dedication to innovation and scientific excellence. From our cutting-edge laboratories to groundbreaking discoveries, the images below provide a glimpse into the world of AI-powered drug discovery and our relentless pursuit of personalized cancer therapies.
